天域生物
(603717)
| 流通市值：32.06亿 | | | 总市值：32.06亿 |
| 流通股本：2.90亿 | | | 总股本：2.90亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 412,302,956.07 | 225,272,371.07 | 801,506,706.66 | 624,472,530.5 |
| 营业收入 | 412,302,956.07 | 225,272,371.07 | 801,506,706.66 | 624,472,530.5 |
| 二、营业总成本 | 418,339,106.17 | 226,794,913.72 | 848,060,136.01 | 594,720,864.52 |
| 营业成本 | 351,962,266.79 | 190,100,655.77 | 714,680,430.17 | 501,189,408.91 |
| 税金及附加 | 726,639.04 | 381,745.06 | 2,130,173.78 | 1,219,476.68 |
| 销售费用 | 1,899,801.48 | 910,389.17 | 4,541,607.34 | 2,854,511.23 |
| 管理费用 | 39,662,854.21 | 17,447,820.1 | 105,129,417.07 | 73,712,418.87 |
| 研发费用 | 7,423,736.22 | 4,320,459.41 | 11,611,258.64 | 6,607,811.49 |
| 财务费用 | 16,663,808.43 | 13,633,844.21 | 9,967,249.01 | 9,137,237.34 |
| 其中:利息费用 | 27,296,261.71 | 12,132,363.84 | 36,528,507.72 | 25,342,543.25 |
| 其中:利息收入 | 16,275,989.15 | 381,966.69 | 29,681,457.65 | 19,044,788.9 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | -428,240 | -82,458.54 |
| 加:投资收益 | -1,060,660.84 | 24,904.75 | 214,519.02 | 487,708.97 |
| 资产处置收益 | 25,911,620.61 | 24,100,263.3 | -665,551.31 | -469,532.31 |
| 资产减值损失(新) | 7,161,672.76 | -42,055.87 | -15,837,153.91 | 7,322,808.98 |
| 信用减值损失(新) | -3,008,690.21 | 4,227,519.86 | -27,361,848.82 | -12,106,516.72 |
| 其他收益 | 284,907.14 | 97,225.14 | 960,779.18 | 683,392.04 |
| 四、营业利润 | 23,252,699.36 | 26,885,314.53 | -89,670,925.19 | 25,587,068.4 |
| 加:营业外收入 | 10,298,004.56 | 765,285.4 | 7,960,815.07 | 7,370,164.14 |
| 减:营业外支出 | 916,075.49 | 379,850.61 | 5,448,273.34 | 5,771,417.83 |
| 五、利润总额 | 32,634,628.43 | 27,270,749.32 | -87,158,383.46 | 27,185,814.71 |
| 减:所得税费用 | 765,007.12 | 174,772.76 | -315,270.97 | -95,316.9 |
| 六、净利润 | 31,869,621.31 | 27,095,976.56 | -86,843,112.49 | 27,281,131.61 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 31,869,621.31 | 27,095,976.56 | -86,843,112.49 | 27,281,131.61 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 10,818,017.08 | 13,768,228.59 | -107,357,787.62 | 6,387,662.07 |
| 少数股东损益 | 21,051,604.23 | 13,327,747.97 | 20,514,675.13 | 20,893,469.54 |
| 扣除非经常损益后的净利润 | -19,301,739.02 | -6,389,156.76 | -113,140,581.89 | -1,720,650.19 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.04 | 0.05 | -0.37 | 0.02 |
| (二)稀释每股收益 | 0.04 | 0.05 | -0.37 | 0.02 |
| 九、综合收益总额 | 31,869,621.31 | 27,095,976.56 | -86,843,112.49 | 27,281,131.61 |
| 归属于母公司股东的综合收益总额 | 10,818,017.08 | 13,768,228.59 | -107,357,787.62 | 6,387,662.07 |
| 归属于少数股东的综合收益总额 | 21,051,604.23 | 13,327,747.97 | 20,514,675.13 | 20,893,469.54 |
| 公告日期 | 2025-08-30 | 2025-04-30 | 2025-04-16 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |